PLAT and intracranial hemorrhage: Additionally, three patients presented with calcification in their CCM, with two experiencing symptomatic intracranial hemorrhage.<h4>Conclusion</h4>The observed incidence of symptomatic intracranial hemorrhage following intravenous tissue plasminogen activator administration appears to be elevated in patients with CCM.